Sarah Giorgia Grazia Giannone/LinkedIn
Jul 26, 2026, 14:45
Sarah Giorgia Grazia Giannone: An Exciting Chapter in Gene Therapy Research
Sarah Giorgia Grazia Giannone, Research Assistant at San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), shared a post on LinkedIn:
“Happy to share that last week I attended the Società Italiana di Terapia Genica e Cellulare (SITGEC) Annual meeting at San Raffaele in Milan, where I had the occasion to present my first poster on the project I’ve been working on since my Master’s thesis.
Grateful for this opportunity and looking forward to the next steps!”

Stay updated with Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines